smbenlazar Profile Banner
Benlazar S M A Profile
Benlazar S M A

@smbenlazar

Followers
9K
Following
14K
Media
6K
Statuses
12K

Professor of hematology, Universitary hospital of Sidi Bel Abbés. Head, Hospitalisation and Geriatric Unit.

Sidi Bel Abbés, Algeria
Joined April 2016
Don't wanna be here? Send us removal request.
@smbenlazar
Benlazar S M A
@smbenlazar
3 days
Giant Proerythroblast showing dog ear-like cytoplasmic pseudopodia (due to Parvovirus B19) with Pure red cell aplasia, Bone marrow aspiration
Tweet media one
0
25
79
@smbenlazar
Benlazar S M A
@smbenlazar
4 days
Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results #leusm
Tweet media one
1
13
43
@smbenlazar
Benlazar S M A
@smbenlazar
4 days
With a high rate of ≥grade 3 toxicities, Is BrECADD better than Nivo AVD in elderly patients with advanced Hodgkin lymphoma? .>>>PET–Guided BrECADD in Older Patients With Advanced-Stage Classic HL
Tweet card summary image
ascopubs.org
PURPOSEPositron emission tomography (PET)-guided therapy with 4-6 cycles of brentuximab vedotin, etoposide, cyclophosphamide, doxorubicin, dacarbazine, and dexamethasone (BrECADD) is highly effective...
0
2
10
@smbenlazar
Benlazar S M A
@smbenlazar
8 days
Hairy cell #leusm #HCL
Tweet media one
0
15
69
@smbenlazar
Benlazar S M A
@smbenlazar
11 days
Aggressive NK Cell Leukemia: Marrow Aspirate | ASH Image Bank | American Society of Hematology #ASHImageBank
Tweet media one
0
17
69
@smbenlazar
Benlazar S M A
@smbenlazar
11 days
hepatosplenic T cell lymphoma | ASH Image Bank | American Society of Hematology #ASHImageBank
Tweet media one
0
6
23
@smbenlazar
Benlazar S M A
@smbenlazar
11 days
RT @Mohty_EBMT: Relapsed/refractory multiple myeloma: standard of care management of patients in the Gulf region | Published in Clinical He….
Tweet card summary image
chi.scholasticahq.com
By Ahmad Alhuraiji, Khalil Al Farsi & 8 more. While these agents are not yet widespread in the Gulf region, we advocate their use where available and discuss strategies to manage and minimize common...
0
12
0
@smbenlazar
Benlazar S M A
@smbenlazar
11 days
Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells #mdpicancers via @Cancers_MDPI #lymsm
Tweet media one
0
5
41
@smbenlazar
Benlazar S M A
@smbenlazar
11 days
Chronic Lymphocytic Leukemia: Novel Therapeutic Targets Under Investigation #mdpicancers via @Cancers_MDPI #leusm
Tweet media one
2
19
73
@smbenlazar
Benlazar S M A
@smbenlazar
11 days
Molecular Pathways and Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) #mdpicancers via @Cancers_MDPI #lymsm
Tweet media one
0
4
14
@smbenlazar
Benlazar S M A
@smbenlazar
12 days
RT @medicalwatchBC: Hi friends, it's #AcuteMyeloidLeukemia Thursday. Here are Top Posts of the Week! 🎉🎉🎉. 1/ Our friend @smbenlazar with a….
0
6
0
@smbenlazar
Benlazar S M A
@smbenlazar
16 days
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management #AML #leusm
Tweet media one
2
92
245
@smbenlazar
Benlazar S M A
@smbenlazar
16 days
A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia #AML #leusm
Tweet media one
0
15
59
@smbenlazar
Benlazar S M A
@smbenlazar
17 days
Good for a prolonged survival #CLL #leusm.-Smudge cells - 1. | ASH Image Bank | American Society of Hematology #ASHImageBank
Tweet media one
1
5
45
@smbenlazar
Benlazar S M A
@smbenlazar
17 days
Plasma Cell Crystalline Inclusions in ALK‐Negative Anaplastic Large Cell Lymphoma - Kinoshita - 2025 - eJHaem - Wiley Online Library
Tweet media one
0
13
51
@smbenlazar
Benlazar S M A
@smbenlazar
17 days
Tweet media one
1
0
4
@smbenlazar
Benlazar S M A
@smbenlazar
19 days
Proposed therapeutic algorithm for mantle cell lymphoma including both clinically available and experimental drugs, expected in the near future #lymsm
Tweet media one
0
22
71
@smbenlazar
Benlazar S M A
@smbenlazar
19 days
Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells #mdpicancers via @Cancers_MDPI
Tweet media one
0
5
44
@smbenlazar
Benlazar S M A
@smbenlazar
19 days
Chronic lymphocytic leukaemia extravaganza: Vacuolated lymphoma cells
Tweet media one
0
10
27
@smbenlazar
Benlazar S M A
@smbenlazar
24 days
Treatment algorithm for frontline Ph-positive.B-cell ALL (2025 Update) @DrHKantarjian @MDAndersonNews #leusm
Tweet media one
0
27
116